◀ Back to PARP1

CXCL9 — PARP1

Text-mined interactions from Literome

Lam et al., Invest Ophthalmol Vis Sci 1999 : The efficacy of Ac-Tyr-Val-Ala-Asp-CMK ( YVAD-CMK ), a peptidyl caspase inhibitor, and 3-aminobenzamide ( ABA ), an inhibitor of poly ( ADP-ribose ) polymerase ( PARP ), in ameliorating the loss of inner retinal elements was evaluated using morphometry to examine the apoptotic pathways
Kanemitsu et al., Blood 2005 : In vitro, CXCL13 activated the small guanosine triphosphatase ( GTPase ) Rap1 in B cells, and corroborating this observation, a deficiency of RAPL, the Rap1 effector molecule, caused a significant reduction in shear-resistant B-cell adhesion to intercellular adhesion molecule 1 ( ICAM-1 )